Unrelated donor hematopoietic stem cell transplantation for the treatment of non‐malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection

Publisher: John Wiley & Sons Inc

E-ISSN: 1096-8652|90|11|1021-1026

ISSN: 0361-8609

Source: AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.11, 2015-11, pp. : 1021-1026

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract